Heavily Pregnant Mom Captures Bump, Not Knowing Soon Her Baby Will Be Gone
Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content.
A woman's once-joyful video of her surprise pregnancy belly has become a painful reminder of tragedy in a post online.
An Instagram reel showing Wendy Thao cradling her pregnant belly now carries a heartbreaking truth: the baby she was expecting would soon be lost to stillbirth. Thao is now sharing her story of profound loss and the journey of navigating grief while embracing new life online. She spoke about this with Newsweek, explaining how she manages the expectations of motherhood while going through the impossible.
"She doesn't know it yet, but her seemingly healthy surprise pregnancy will end in a stillbirth at 33 weeks," Thao captioned her video. "If you're new here and don't know Delilah's story, she was born sleeping at 33 weeks due to a sudden, unexpected placental abruption. I felt her kick at noon, and by 5:00 p.m., she was gone.
"There were no signs, no reasons—just an unbearable silence where life should've been. She was perfect in every way, just too perfect for this world."
Photos from Wendy Thao's Instagram reel which show her pregnant with her late baby, Delilah.
Photos from Wendy Thao's Instagram reel which show her pregnant with her late baby, Delilah.
@ourlovinghive/Instagram
Thao told Newsweek that everything halted the moment she learned of her daughter, Delilah's, passing.
"It felt like the world stopped," she said. "I remember sitting in the ultrasound room, holding my breath, watching the technician's face change...I knew something was wrong before anyone said a word. When they finally told me there was no heartbeat, it felt like I left my body. Like I was watching someone else's life fall apart."
The experience of delivering Delilah was profoundly painful. She remembered going to the hospital to deliver a baby she knew was already gone.
"The silence in the delivery room was deafening," she said. "No cries, just silence. Holding her in my arms was both the most beautiful and the most painful moment of my life. She was perfect. And yet, I knew I'd never get to watch her grow."
'Eleanor Saved Me'
It wasn't the first time Thao had lost a child—before Delilah, she had had a miscarriage. But Thao now has another child, Eleanor, leaving her to navigate immense love and grief at once.
"As I hold my sweet Eleanor sleeping on my chest, I can't help but think of the babies I've lost," she wrote in her caption. "Never in a million years did I imagine I'd lose two."
Navigating grief while caring for Eleanor has been a delicate balance.
"There were days I felt completely shattered, like a part of me was missing," Thao said. "But in many ways, Eleanor saved me. She taught me that it's okay to grieve and still feel joy and love...Some days, staying present meant simply holding her close and breathing through the tears. Other days, it meant laughing with her and allowing myself to feel joy without guilt."
For others experiencing similar loss, she offered advice. "Let yourself feel it all. There is no 'right' way to grieve, and no timeline for healing," she said. "Lean into your support system, even when it's hard to ask for help. Say their name. Talk about your baby. They existed. They mattered. And they always will.
"There were so many moments when I felt completely alone in my grief, like no one could possibly understand the ache of loving someone you never got to bring home. If sharing Delilah's story helps even one person feel less isolated in that darkness, then her life continues to have meaning in this world."
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Newsweek
6 hours ago
- Newsweek
Chocolate Recall Sparks Nationwide Warning to Customers
Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. Neuhaus Chocolates NV is recalling their Belgian Chocolate Moments Smurfs 'Popping Milk Chocolates with Cookies because the product contains wheat which was not declared on the packaging. Newsweek reached out to the company via email Monday for comment. Why It Matters Numerous recalls have been initiated this year due to the potential for damaged products, foodborne illness, contamination and undeclared food allergens. Millions of Americans experience food sensitivities or allergies every year. According to the U.S. Food and Drug Administration (FDA), the nine "major" food allergens in the U.S. are eggs, milk, fish, wheat, soybeans, Crustacean shellfish, sesame, tree nuts and peanuts. People with a wheat allergy could experience a "serious or life-threatening allergic reaction if they consume these products," the FDA warns. What To Know Neuhaus Chocolate can be seen related to a recall in August 2025. (Photo from the U.S. Food and Drug Administration) Neuhaus Chocolate can be seen related to a recall in August 2025. (Photo from the U.S. Food and Drug Administration) In the alert, the FDA says the recalled chocolates were distributed from July 21, 2025, until August 4, 2025, by Neuhaus stores in Virginia, New York, Pennsylvania, Maryland, Washington, D.C. and via their online store. The impacted batch numbers are 80108690 and 80108763 with a best use before date of January 13, 2026, the FDA alert says. There have been no reports of illnesses related to this recall and 150 units of the impacted products were sold, the FDA says. What People Are Saying The FDA in their alert in part: "The action was initiated after it was discovered during an internal check that product containing wheat was distributed in packaging that did not reveal the presence of wheat. Subsequent investigation indicates the problem was caused by an exceptional combination of circumstances in which the ERP (Enterprise Resource Planning) did not include the allergen on the packaging." In an email to Newsweek in January, the FDA said: "Most recalls in the U.S. are carried out voluntarily by the product manufacturer and when a company issues a public warning, typically via news release, to inform the public of a voluntary product recall; the FDA shares that release on our website as a public service. "The FDA's role during a voluntary, firm-initiated, recall is to review the recall strategy, evaluate the health hazard presented by the product, monitor the recall, and as appropriate alert the public and other companies in the supply chain about the recall. "The FDA provides public access to information on recalls by posting a listing of recalls according to their classification in the FDA Enforcement Report, including the specific action taken by the recalling company. The FDA Enforcement Report is designed to provide a public listing of products in the marketplace that are being recalled." Additional information on recalls can be found via the FDA's Recalls, Market Withdrawals, & Safety Alerts. What Happens Next Customers who have purchased the recalled product who have a wheat allergy are asked to return it to the original place of purchase and not to consume it, the FDA says. People with additional questions may contact the company via phone at +32 2 568 23 00 from 8 a.m. to 5 p.m. Central European Summer Time on weekdays or via email at customercare@
Newsweek
6 hours ago
- Newsweek
New Vaccine Shows Promise Against One of the Deadliest Cancers
Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. Early clinical and preclinical results are showing that experimental mRNA and nanoparticle vaccines produced measurable immune responses against pancreatic cancer, one of the deadliest cancers, and that in small patient groups those immune responses correlated with delayed recurrence or prolonged survival. Why It Matters Pancreatic cancer has among the lowest survival rates of common cancers and limited effective treatments. Multiple small trials and preclinical studies published and reported in the past year indicated that novel vaccine platforms, including personalized mRNA vaccines and layered lipid nanoparticles, were able to induce tumor‑targeting T cells in patients and animal models, prompting researchers to plan larger trials. Pancreatic ductal adenocarcinoma had an approximate five‑year survival near 13 percent in recent reports, making it one of the most lethal common cancers. What To Know Researchers at Memorial Sloan Kettering (MSK) and collaborators ran a phase 1 trial in February testing a personalized mRNA vaccine called autogene cevumeran (BNT122, RO7198457) in 16 patients with operable pancreatic cancer who received surgery, chemotherapy and the vaccine, according to the peer reviewed journal Nature Medicine. Newsweek reached out to MSK via email for comment. The vaccine was developed and researched through a collaboration between BioNTech, an immunotherapy company, and Genentech, a member of the Roche Group. It is not a cure for the type of cancer itself; however, signs point to improving longevity in individuals who contract the disease. Investigators reported that half of participants mounted vaccine‑induced tumor‑specific T‑cell responses. Also, long-term efficacy was reported as patients with a vaccine-induced immune response had a reduced risk of cancer returning at three-year follow-up appointments compared with patients whose immune systems did not respond. Trials have occurred as cancer is on the rise this year compared to last, according to the American Cancer Society's 2025 annual Facts & Figures report. More than 2 million new cancer cases are expected this year, according to a 48-page report. Roughly 618,000 Americans are expected to die from cancer in 2025, equating to about 1,700 deaths per day, and both one-in-three men and women are said to develop cancer in their lifetime. These five cancers are predicted to take nearly 323,900 male lives in a year: Lung and bronchus—64,190 male deaths Prostate—35,770 male deaths Colon and rectum—28,900 male deaths Pancreas—27,050 male deaths Liver and intrahepatic bile duct—19,250 male deaths These five cancers are estimated to take nearly 294,220 female lives in a year, described by researchers as a "substantial" increase compared to 2024 numbers: Lung and bronchus—60,540 female deaths Breast—42,170 female deaths Pancreas—24,930 female deaths Colon and rectum—24,000 female deaths Uterine—13,860 female deaths Researchers reported early clinical and preclinical results showing that experimental mRNA and nanoparticle vaccines produced measurable immune responses against pancreatic cancer. Researchers reported early clinical and preclinical results showing that experimental mRNA and nanoparticle vaccines produced measurable immune responses against pancreatic cancer. Getty Images What People Are Saying Vinod Balachandran, a surgical oncologist at MSK and principal investigator of the February 2025 trial, said at the time of the trial's conclusion: "The latest data from the phase 1 trial are encouraging. They suggest this investigational therapeutic mRNA vaccine can mobilize anti-tumor T cells that may recognize pancreatic cancers as foreign, potentially years after vaccination." He added: "For patients with pancreatic cancer, our latest results continue to support the approach of using personalized mRNA vaccines to target neoantigens in each patient's tumor. If you can do this in pancreas cancer, theoretically you may be able to develop therapeutic vaccines for other cancer types." Immunologist Li Lily Wang, an associate professor of molecular medicine at the Case Western Reserve School of Medicine, said earlier this year: "This platform has the potential to transform clinical care for this devastating disease. I am excited to see that our novel nano-vaccine worked so well in eliciting vigorous responses from tumor-reactive T cells-which are typically low in numbers and unable to control tumor growth." What Happens Next? Researchers planned larger trials to test whether the vaccine‑induced immune responses translated into longer survival and lower recurrence rates. MSKCC and industry partners launched a phase 2 trial to evaluate the personalized pancreatic mRNA vaccine in a larger cohort following the encouraging phase 1 immune data. Across studies, authors and outside experts urged caution because the human data remained small. Investigators and commentators said larger randomized trials were necessary to determine whether the immune responses would translate into durable survival benefits and acceptable safety in broader patient populations.
Newsweek
6 hours ago
- Newsweek
Weight Loss May Improve Pregnancy Odds
Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. Weight loss interventions for people who are overweight and obese undertaken before turning to IVF could increase the chances of getting pregnant naturally. This is the conclusion of researchers from University of Oxford who reviewed 12 past studies involving nearly 2,000 patients from 1980 to May of this year. They compared a woman's weight to how likely they were to become pregnant either without IVF (unassisted pregnancy), with IVF (treatment-induced pregnancy) and overall (unassisted plus treatment-induced)—as well as whether they delivered a live baby. "All participants in the included studies were candidates for IVF. Before having IVF, they were offered weight loss support. The women who got pregnant naturally, ended up not needing to have IVF," study author and dietician Moscho Michalopoulou told Newsweek. Side view pregnant woman with advanced pregnant belly belly in hands. Side view pregnant woman with advanced pregnant belly belly in criteria included studies conducted on women who were at least 18 years old with a BMI of 27 kg/m² or greater who were seeking IVF with or without intracytoplasmic sperm injection treatment (ICSI) for infertility. "IVF and ICSI are assisted reproductive techniques where oocytes [cells involved in reproduction] are fertilized outside the body, before embryos are transferred back into the woman's womb. The key difference is how the fertilization is achieved," Michalopoulou explained. "Regular IVF egg and sperm are typically mixed in a Petri dish, with ICSI, the sperm is directly injected into the egg." The researchers found that participants were typically women in their early 30s with a median baseline BMI of 33.6 kg/m². The weight loss interventions studied included low-energy diets, an exercise program accompanied by healthy eating advice and pharmacotherapy accompanied by diet and physical activity advice. "Low-energy diets, also known as total diet replacements, typically use liquid formula products to replace real food and induce a much larger energy deficit with total energy intake of no more than 1000 kcal/day, followed by gradual reintroduction of foods for weight stabilization," Michalopoulou explained. She said these are safe for women when supervised and supported to follow such a program, with a lot of literature on the effectiveness of these diets. "In this one study, the main intervention being tested was high-intensity interval training (referenced as Kiel 2018 in the paper). At the same time, participants were advised to eat healthy as per national healthy eating recommendations," said Michalopoulou. In terms of the 'pharmacotherapy' intervention, she added, "Participants were instructed to take weight loss medication which was the main intervention being tested, but at the same time, they were given healthy eating advice or a hypocaloric diet [low in calories], plus advice on how to increase their physical activity, e.g. doing more steps, or doing exercise." Overall, weight loss interventions before IVF were associated with greater unassisted pregnancy rates, according to the researchers. "Regardless of weight loss method used, across all studies, women with obesity who participated in a supported weight loss program before IVF had 47 percent higher chances of getting pregnant naturally, compared to women in the comparator groups who typically received standard care," said Michalopoulou. "Therefore, more women in the intervention than in the comparator groups did not need to have IVF treatment to get pregnant, as they got pregnant naturally." However, evidence was inconclusive on the effect of weight loss interventions on treatment-induced pregnancies. Illustration representing IVF process with eggs fertilized with sperm. Illustration representing IVF process with eggs fertilized with sperm."It is unclear if weight loss interventions before IVF have an effect on the chances of getting pregnant through IVF. In some studies there were more IVF pregnancies in the intervention groups compared to standard care, in some others there were fewer IVF pregnancies compared to standard care—and in some others there was no difference in IVF pregnancy rates compared to standard care," Michalopoulou explained. "This large variability, combined with other methodological issues of the included studies, prevent us from having a clear conclusion on whether weight loss programs before IVF have an effect on IVF-induced pregnancy success or not." Evidence on the association between weight loss interventions before IVF and live births was uncertain—mainly because there were fewer studies that reported live birth outcomes—although there was moderate certainty of no association with pregnancy loss. "Obesity can lead to female infertility through hormone imbalance, insulin resistance, inflammation, and polycystic ovary syndrome. All of these can lead to ovulatory dysfunction," said Michalopoulou. "Obesity has also been associated with lower IVF success for women with infertility, such as requiring higher doses of treatment, reduced response to the medications, reduced chances of getting pregnant, and increased chances of miscarriage if a pregnancy is achieved." "Maintaining a healthier weight can help improve hormone balance, increase insulin sensitivity, reduce inflammation, and improve ovulation. For women seeking IVF, lowering their BMI to healthier levels may improve sensitivity and response to the treatment, improve egg quality and uterine function, and as a result, increase their chances of getting pregnant." However, everyone is different, the researcher noted. "Many larger women will have healthy pregnancies. But evidence shows that starting pregnancy carrying too much weight and gaining too much weight during pregnancy are both associated with greater risks of complications. This does not mean that every woman living with obesity will develop these complications—just that there will likely be more complications than in women who start pregnancy in the normal BMI range" The researchers hope their systematic review and analysis of randomized controlled trials will lead to more advanced trials. "We already know weight loss can help with fertility, but whether it improves IVF outcomes is far less certain. This review sheds some light, but most of the studies are small and at high risk of bias, so the results need cautious interpretation. IVF bypasses many obesity-related barriers, but what is still unclear is if delaying treatment for weight loss truly boosts success rates," said Ying Cheong—a professor of reproductive medicine of the University of Southampton who was not involved in the present study—in a statement. "Weight loss interventions before IVF appear to increase the chances of pregnancy, especially through natural conception, which may negate the need for IVF treatment, and does not seem to increase the risk of pregnancy loss. This offers hope to women with obesity and infertility," Michalopoulou said. "However, the evidence is limited and unclear on whether weight loss interventions before IVF have an effect on live birth rates, and more evidence from larger, high-quality trials is needed to test this." Do you have a tip on a health story that Newsweek should be covering? Do you have a question about pregnancy? Let us know via health@ Reference Michalopoulou, M., Jebb, S. A., Hobson, A., Khaw, S. C., Stevens, R., Melo, P., Haffner, S. J. P., Clay, K. S., Mounsey, S., Granne, I., Lim, L., Child, T., & Astbury, N. M. (2025). The effect of weight loss before in vitro fertilization on reproductive outcomes in women with obesity: A systematic review and meta-analysis. Annals of Internal Medicine, 178(9).
